Asset restraint orders against OTC providers



The corporate watchdog has applied for interim asset restraint orders against two over the counter (OTC) derivatives providers while it pursues investigations.
The Australian Securities and Investments Commission (ASIC) applied to the Federal Court for the restraint orders against Maxi EFX Global AU Pty Ltd (trading as EuropeFX) and BrightAU Capital Pty Ltd (trading as TradeFred), both of which are Corporate Authorised Representatives of Union Standard International Group Pty Ltd (trading as USGFX).
Currently, there have been no findings of contraventions of the Corporations Act against any party.
An ASIC announcement said: “On 12 December 2019, the Court also made asset restraint orders against USGFX on an ex parte basis.
“On 17 December 2019, those orders were vacated by the Court. USGFX gave an undertaking to the Court to keep amounts of $182,000 and $53,067.33 in a separate bank account. No further asset restraint orders were made against USG.”
The asset restraint orders did not prevent EuropeFX and TradeFred from making payments in the ordinary course of business to customers or creditors, ASIC said.
It noted that the Court also restricted overseas travel of USGFX and TradeFred director, John Carlton Martin. EuropeFX director, Pedro Eduardo Sasso, would need to notify ASIC prior to leaving Australia.
The matter will be before court on 17 February, 2020.
Recommended for you
The corporate regulator has cancelled the AFSL of a Perth advice firm with the firm having previously seen its licence temporarily suspended in 2020.
Having proposed changes earlier this year, ASIC has clarified how it will support licensees with additional relief under the reportable situations regime.
AMP has partnered with BlackRock and research house Lonsec to provide a model portfolio capability on its North platform that offers “portfolio customisation at scale” to advice practices of all sizes.
Money Management rounds up actions ASIC took against advice individuals in the first half for FY25 from exam falsifications to dishonest conduct.